Prognosis
Singapore to Begin Virus Vaccine Human Trials This Week, ST Says
This article is for subscribers only.
Singapore will start human trials as early as this week for a Covid-19 vaccine being developed by Duke-NUS Medical School and American pharmaceutical company Arcturus Therapeutics, the Straits Times reports.
‘Lunar-Cov19’ is among 25 vaccine candidates globally to reach human-trials stage and will be tested on 108 healthy volunteers of various ages in Singapore, the newspaper said.